Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/05/2003CN1453366A Micro sprue system of biochip array
11/05/2003CN1453365A Biochip array
11/05/2003CN1453364A Tumor drug resistant marker gene and its use as target point for design of medicine for drug resisting tumor
11/05/2003CN1453363A DNA chip for diagnosing Mediterranean anemia and its prepn
11/05/2003CN1453359A Chinese cabbage fertility relevant gene and method of using the gene in constituting artificial male sterility line of Chinese cabbage and similar crops
11/05/2003CN1453358A Nucleotide specific to ogawa of colibacillus 0-59
11/05/2003CN1453357A Fat-type fatty acid bindin gene of chicken and its cloning and identification method
11/05/2003CN1452857A Molecule labeling method for female gene of jie gourd
11/05/2003CN1126819C Homogeneous molecular lampmark fluorescent probe PCR hepatitis B virus detecting method and reagent kit
11/05/2003CN1126454C Control of enterohemorrhagic E Coli 0157:H7 of cattle with probiotic bacteria
11/04/2003US6643591 Use of computational and experimental data to model organic compound reactivity in cytochrome P450 mediated reactions and to optimize the design of pharmaceuticals
11/04/2003US6642438 Melon promoters for expression of transgenes in plants
11/04/2003US6642374 Batch process where polynucleotides are separated using nonpolar beads, a counterion agent and stripping solvent to release given size of polynucleotides from beads; MIPC (Matched Ion Polynucleotide Chromatography)
11/04/2003US6642370 Isolated nucleic acid encoding mutations in gene for CD2 binding proteins; use in drug screening and diagnosis of familial recurrent and juvenile rheumatoid arthritis
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642362 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642062 Multihued labels
11/04/2003US6642055 Method for the prediction of preeclampsia and other diseases
11/04/2003US6642048 Conditioned media for propagating human pluripotent stem cells
11/04/2003US6642040 Human cGMP-stimulated cyclic nucleotide phosphodiesterase
11/04/2003US6642034 Multiple displacement amplification
11/04/2003US6642033 Contacting sample with primers pairs of given sequence; annealing; extending using a polymerase
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections
11/04/2003US6642017 Modulating production of pneumococcal capsular polysaccharide
11/04/2003US6642016 Biosensor and its use to indicate the status of a product
11/04/2003US6642015 Biocompatible membrane; for use in the measurement of particles in a tissue
11/04/2003US6642014 Enzyme activity screen with direct substrate replacement
11/04/2003US6642010 Identifying, monitoring, and treating women for breast precancer or cancer
11/04/2003US6642009 Diagnosis of breast cancer by isolating a ductal fluid sample from one duct not mixed with other fluid from other ducts and not being discharged spontaneously; determining the presence/absence of a marker associated with cancer
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6642005 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
11/04/2003US6642004 Method for measuring nucleotides
11/04/2003US6642002 Method of diagnosing pulmonary hypertension
11/04/2003US6642001 Single base extension (SBE); fluorescence resonance energy transfer (FRET); determining identity of nucleotides in a sequence using a probe comprising a fluorescent molecule, primer and labeled dideoxynucleotide
11/04/2003US6642000 Using hydrophobic liquid; identifying products by hybridization and melting curve analysis; efficiency
11/04/2003US6641994 Methods of identifying anti-viral agents
11/04/2003CA2040555C Cloned glutamic acid decarboxylase
10/2003
10/30/2003WO2003090169A1 Method for separating a group of cells which are contained in an image sample into individual cells
10/30/2003WO2003089936A1 Aberrant-specific pathways
10/30/2003WO2003089933A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis
10/30/2003WO2003089932A1 Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2
10/30/2003WO2003089930A1 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
10/30/2003WO2003089928A1 Test for measurement of therapeutic drug levels
10/30/2003WO2003089927A2 Antigens associated with haematological malignancy
10/30/2003WO2003089924A1 Determining cancer aggressiveness
10/30/2003WO2003089922A1 Method for detecting ligands and targets in a mixture
10/30/2003WO2003089906A2 Functionalized nanoparticles and methods of use
10/30/2003WO2003089904A2 Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
10/30/2003WO2003089903A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003WO2003089902A2 Displacement assay for detection of small molecules
10/30/2003WO2003089901A2 Methods for preparing libraries of unique tags and related screening methods
10/30/2003WO2003089899A2 Probes for detecting tumor cells
10/30/2003WO2003089898A2 Determining biochemical markers of progression and therapy monitoring and specification, therapeutic lead molecules, and target biochemical systems applied to stroke
10/30/2003WO2003089897A2 Diagnosis and treatment of vascular disease
10/30/2003WO2003089895A2 Methods for the electrochemical detection of multiple target compounds
10/30/2003WO2003089894A2 Isothermal amplification in nucleic acid analysis
10/30/2003WO2003089805A2 Collision energy-absorbing device
10/30/2003WO2003089672A1 Hepatitis c virus assay systems
10/30/2003WO2003089671A1 'doping' in walk-through mutagenesis
10/30/2003WO2003089670A2 Reagents for monitoring nuclei acid amplification and methods of using same
10/30/2003WO2003089669A1 Novel method of assaying nucleic acid
10/30/2003WO2003089668A2 Differentially expressed genes in conjunctivial pterygium
10/30/2003WO2003089667A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/30/2003WO2003089665A1 Methods for measuring protein kinase and phosphatase activity
10/30/2003WO2003089664A1 Methods for screening for a compound useful in the treatment or prevention of lymphocytic disorders, for inhibiting lymphocyte activity and preventing or treating lymphocytic disorders
10/30/2003WO2003089663A2 Methods for measuring enzyme activity
10/30/2003WO2003089661A1 Method and apparatus for detection of bioaerosols
10/30/2003WO2003089660A1 Disposable sub-microliter volume sensor with enhanced sample inlet
10/30/2003WO2003089658A1 Disposable sensor with enhanced sample port inlet
10/30/2003WO2003089657A1 Method for phenotyping using nmr spectroscopy
10/30/2003WO2003089656A1 Methods and compound mixtures for determining protein activity using nmr spectroscopy
10/30/2003WO2003089655A1 Device for retaining samples for biodetectors
10/30/2003WO2003089654A2 Single nucleotide polymorphism analysis using surface invasive cleavage reactions
10/30/2003WO2003089652A2 Comparative phenotype analysis of cells, including testing of biologically active compounds
10/30/2003WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof
10/30/2003WO2003089637A1 Mutation of dna polymerases from archaeobacteria
10/30/2003WO2003089635A1 Cytotoxicity assay
10/30/2003WO2003089627A1 Translocation dependent complementation for drug screening
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089615A2 Antiviral inhibitions of capsid proteins
10/30/2003WO2003089609A2 Short fragment homologous replacement to provide bse resistant cattle
10/30/2003WO2003089606A2 Thermostable dna polymerases and methods of making same
10/30/2003WO2003089605A2 Method of creating a library of bacterial clones with varying levels of gene expression
10/30/2003WO2003089594A2 A device and methods for concentrating prion protein isoforms
10/30/2003WO2003089589A2 Matrix analysis of gene expression in cells (magec)
10/30/2003WO2003089587A2 Method to enhance homologous recombination
10/30/2003WO2003089586A2 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye
10/30/2003WO2003089585A2 Methods of use of the enzymes of mycothiol synthesis
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089564A1 Substrate and method for measuring the electrophysiological properties of cell membranes
10/30/2003WO2003089463A1 Purified (3r)-hydroxymyristoyl-(acyl-carrier-protein) dehydratase polypeptide from pseudomonas aeruginosa
10/30/2003WO2003089457A2 Peptide inhibitors of protein kinase c ϝ for pain management
10/30/2003WO2003089456A2 Peptide inhibitors of protein kinase c
10/30/2003WO2003089003A1 Methods of treatment and diagnosis of patients with hepatitis c infection
10/30/2003WO2003088990A1 Plasma protein-binding ligands
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof